Chris Mirabile’s journey into health and longevity began with a preteen’s desire to impress girls during school fitness tests—but quickly evolved into something deeper. By age 12, Chris was reading Men’s Health, refining his diet, and obsessing over performance, though he later realized much of his early approach to health was misguided. At 16, his life took a dramatic turn when he suffered a seizure during a school field trip and was diagnosed with a large brain tumor. Emergency brain surgery saved his life, but the experience left a lasting impression, igniting a relentless drive to understand human biology and wellness.
Though he studied finance and entrepreneurship at NYU, Chris immersed himself in scientific research, especially in bio-gerontology—the biology of aging. Long before it was a buzzword, he was poring over PubMed studies, using genetic testing tools, and analyzing his own DNA to uncover predispositions that might have contributed to his tumor. After early success and eventual failure with a social media startup, Chris doubled down on his passion for health optimization. He founded Novos, a company dedicated to slowing the aging process through science-backed supplements and nutrition, collaborating with researchers from institutions like Harvard, MIT, and the Salk Institute.
Today, Chris combines rigorous science with real-world application. He launched NovoScore, a daily supplement targeting all 12 known mechanisms of aging, and developed a science-forward meal replacement bar that emphasizes longevity-promoting ingredients over trendy marketing. Through Novos and his personal platform SlowMyAge, Chris educates others on optimizing biological age, drawing from cutting-edge research in omics sciences and data-driven health tracking. With over 10 million supplement doses taken and partnerships expanding, Chris’s mission is clear: to empower people to live longer, healthier, and more vibrant lives through informed, evidence-based choices.
